Cargando…
Burden of melioidosis in India and South Asia: Challenges and ways forward
Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few importe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306050/ https://www.ncbi.nlm.nih.gov/pubmed/37383295 http://dx.doi.org/10.1016/j.lansea.2022.03.004 |
_version_ | 1785065857578172416 |
---|---|
author | Mohapatra, Prasanta R Mishra, Baijayantimala |
author_facet | Mohapatra, Prasanta R Mishra, Baijayantimala |
author_sort | Mohapatra, Prasanta R |
collection | PubMed |
description | Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few imported cases from Pakistan have also been reported. India has experienced an increase in numbers of melioidosis cases in the recent years. The bacteria is inherently present in the soil and enters the human body via skin abrasions, inhalation, or ingestion. As clinicians are often ignorant about the similar characteristics of this disease and several other common tropical diseases, it causes a major delay in the timely diagnosis and management. The organism is easily mistaken as Pseudomonas spp in microbiology laboratories and may be dismissed as a common laboratory contaminant. The poor diagnostic sensitivity of blood culture also leads to missed diagnosis. Hence, both clinical ignorance and missed laboratory diagnosis have misrepresented melioidosis as a rare entity. The key preventive interventions are avoiding contact with loose and muddy soils of meliodosis-endemic areas, and provision of safe drinking water. The present article describes the various possible attributes for melioidosis underdiagnosis and the challenges of improving the diagnosis in conjunction with viable solutions. FUNDING: None. |
format | Online Article Text |
id | pubmed-10306050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103060502023-06-28 Burden of melioidosis in India and South Asia: Challenges and ways forward Mohapatra, Prasanta R Mishra, Baijayantimala Lancet Reg Health Southeast Asia Review Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few imported cases from Pakistan have also been reported. India has experienced an increase in numbers of melioidosis cases in the recent years. The bacteria is inherently present in the soil and enters the human body via skin abrasions, inhalation, or ingestion. As clinicians are often ignorant about the similar characteristics of this disease and several other common tropical diseases, it causes a major delay in the timely diagnosis and management. The organism is easily mistaken as Pseudomonas spp in microbiology laboratories and may be dismissed as a common laboratory contaminant. The poor diagnostic sensitivity of blood culture also leads to missed diagnosis. Hence, both clinical ignorance and missed laboratory diagnosis have misrepresented melioidosis as a rare entity. The key preventive interventions are avoiding contact with loose and muddy soils of meliodosis-endemic areas, and provision of safe drinking water. The present article describes the various possible attributes for melioidosis underdiagnosis and the challenges of improving the diagnosis in conjunction with viable solutions. FUNDING: None. Elsevier 2022-05-05 /pmc/articles/PMC10306050/ /pubmed/37383295 http://dx.doi.org/10.1016/j.lansea.2022.03.004 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mohapatra, Prasanta R Mishra, Baijayantimala Burden of melioidosis in India and South Asia: Challenges and ways forward |
title | Burden of melioidosis in India and South Asia: Challenges and ways forward |
title_full | Burden of melioidosis in India and South Asia: Challenges and ways forward |
title_fullStr | Burden of melioidosis in India and South Asia: Challenges and ways forward |
title_full_unstemmed | Burden of melioidosis in India and South Asia: Challenges and ways forward |
title_short | Burden of melioidosis in India and South Asia: Challenges and ways forward |
title_sort | burden of melioidosis in india and south asia: challenges and ways forward |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306050/ https://www.ncbi.nlm.nih.gov/pubmed/37383295 http://dx.doi.org/10.1016/j.lansea.2022.03.004 |
work_keys_str_mv | AT mohapatraprasantar burdenofmelioidosisinindiaandsouthasiachallengesandwaysforward AT mishrabaijayantimala burdenofmelioidosisinindiaandsouthasiachallengesandwaysforward |